Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 441 matching records.
441 results — page 1 of 19
- Level DNarrative ReviewEurope PMC
Migrasomes: Emerging players in intercellular communication and disease pathogenesis (Review)
Narrative Review on Chronic Kidney Disease, Stroke Research, Neuroinflammation, Chronic Inflammation, published in Mol Med Rep (2026) — summary generated from the PubMed abstract.
- 2026
Mol Med Rep - Level DLaboratory StudyEurope PMC
Metabolic beneficial effects of targeting a long non-coding RNA, lnc-megacluster, in obesity
Laboratory Study on Type 2 Diabetes, Chronic Kidney Disease, published in Mol Ther Nucleic Acids (2026) — summary generated from the PubMed abstract.
- 2026
Mol Ther Nucleic Acids1 citations - Level BClinical TrialPubMed
Clinical efficacy and safety of allogeneic adipose-derived stem cells ELIXCYTE in chronic kidney disease: a phase I/II study.
Clinical Trial on Chronic Kidney Disease, published in Stem Cells Transl Med (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cells Transl Med - Level DAnimal StudyPubMed
Effects of Repeated Intravenous Injections of Autologous Adipose-Derived Mesenchymal Stromal Cells Expressing an Allogeneic MHC Protein in a Mouse Model of Diabetic Nephropathy.
Animal Study on Chronic Kidney Disease, Chronic Inflammation, Immune Modulation, published in Cells (2026) — summary generated from the PubMed abstract.
- 2026
Cells1 citations - Level DLaboratory StudyPubMed
Therapeutic Potential of Mesenchymal Stem Cells in Pediatric Kidney Disorders: A Comprehensive Review.
Laboratory Study on Chronic Kidney Disease, Acute Kidney Injury, Immune Modulation, published in Health Sci Rep (2026) — summary generated from the PubMed abstract.
- 2026
Health Sci Rep - Level DNarrative ReviewEurope PMC
Exosomal MicroRNAs as theranostic tools in type 2 diabetes and its complications: mechanistic insights and clinical implications
Narrative Review on Type 2 Diabetes, Chronic Kidney Disease, published in Diabetol Metab Syndr (2026) — summary generated from the PubMed abstract.
- 2026
Diabetol Metab Syndr - Level ASystematic ReviewEurope PMC
Exosomes in diabetic kidney disease: pathogenesis, biomarker discovery, and emerging therapeutics-a comprehensive systematic review
Systematic Review on Chronic Kidney Disease, published in Ren Fail (2026) — summary generated from the PubMed abstract.
- 2026
Ren Fail - Level DNarrative ReviewEurope PMC
Mesenchymal stem cell-derived extracellular vesicles: emerging cell-free therapeutics for kidney diseases
Narrative Review on Chronic Kidney Disease, published in Front Immunol (2026) — summary generated from the PubMed abstract.
- 2026
Front Immunol1 citations - Level DNarrative ReviewEurope PMC
MicroRNA Regulation in Kidney Interstitial Fibrosis
Narrative Review on Chronic Kidney Disease, published in Epigenomes (2026) — summary generated from the PubMed abstract.
- 2026
Epigenomes - Level DNarrative ReviewEurope PMC
Stem cell therapies to modulate harmful immune responses in kidney disease: progress toward clinical validation
Narrative Review on Chronic Kidney Disease, Acute Kidney Injury, Chronic Inflammation, Immune Modulation, published in Stem Cells (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cells - Level BClinical TrialEurope PMC
The role of mesenchymal stem cells in IgA nephropathy: current evidence and future directions
Clinical Trial on Chronic Kidney Disease, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther - Level BRandomized Controlled TrialEurope PMC
Advancing mesenchymal stem cell therapy for kidney diseases in companion animals: from mechanisms to clinical application
Randomized Controlled Trial on Chronic Kidney Disease, Immune Modulation, published in Front Vet Sci (2026) — summary generated from the PubMed abstract.
- 2026
Front Vet Sci - Level BClinical TrialEurope PMC
Allogeneic umbilical cord-derived mesenchymal stromal cells for treatment of refractory lupus nephritis: a real-world study
Clinical Trial on Chronic Kidney Disease, Autoimmune Research, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther - Level DNarrative ReviewEurope PMC
Leveraging extracellular vesicle biology for novel tests and therapeutics for kidney fibrosis
Narrative Review on Chronic Kidney Disease, Chronic Inflammation, published in Clin Transl Med (2026) — summary generated from the PubMed abstract.
- 2026
Clin Transl Med - Level DNarrative ReviewEurope PMC
Urine-derived stem cells in kidney disease: progress, challenges, and future directions
Narrative Review on Chronic Kidney Disease, Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther - Level DNarrative ReviewEurope PMC
NELL-1: role and mechanisms in disease pathogenesis and development
Narrative Review on Chronic Kidney Disease, published in Front Cell Dev Biol (2026) — summary generated from the PubMed abstract.
- 2026
Front Cell Dev Biol - Level DNarrative ReviewEurope PMC
Multifaceted therapeutic potential of saponins in type 2 diabetes mellitus: mechanisms targeting insulin resistance and diabetic complications
Narrative Review on Type 2 Diabetes, Chronic Kidney Disease, published in Front Pharmacol (2026) — summary generated from the PubMed abstract.
- 2026
Front Pharmacol - Level DNarrative ReviewEurope PMC
Exosome-mediated cell-cell communication: a new perspective on the mechanisms and therapeutic potential of diabetic microvascular complications
Narrative Review on Chronic Kidney Disease, Chronic Inflammation, published in Front Pharmacol (2026) — summary generated from the PubMed abstract.
- 2026
Front Pharmacol - Level DAnimal StudyPubMed
Human adipose-derived mesenchymal stem cells ameliorate Diabetic Kidney Disease by restoring macrophage efferocytosis.
Animal Study on Chronic Kidney Disease, Chronic Inflammation, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther - Level DAnimal StudyPubMed
Exosomes from diabetic perirenal adipose-derived MSCs promote inflammation and fibrosis in diabetic nephropathy via the miR-331-3p/TSC1/mTORC1 Axis.
Animal Study on Chronic Kidney Disease, published in Int Immunopharmacol (2026) — summary generated from the PubMed abstract.
- 2026
Int Immunopharmacol - Level DAnimal StudyPubMed
Adipose-derived mesenchymal stem cells improved acute renal failure induced by ischemia-reperfusion injury: Focusing on toll-like receptor 4 activity and endoplasmic reticulum stress response.
Animal Study on Chronic Kidney Disease, Acute Kidney Injury, published in J Physiol Biochem (2026) — summary generated from the PubMed abstract.
- 2026
J Physiol Biochem - Level DNarrative ReviewPubMed
Urine-Derived Stem Cells: Challenges in Isolation, Biological Identity, and Therapeutic Potential in CKD-Associated Fibrosis.
Narrative Review on Chronic Kidney Disease, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci - Level DNarrative ReviewEurope PMC
Glial cell line-derived neurotrophic factor and its role in attenuating renal fibrosis: a review
Narrative Review on Chronic Kidney Disease, Scar, published in Korean J Intern Med (2025) — summary generated from the PubMed abstract.
- 2025
Korean J Intern Med - Level DNarrative ReviewEurope PMC
The role of tissue oxygenation in obesity-related cardiometabolic complications
Narrative Review on Type 2 Diabetes, Chronic Kidney Disease, published in Rev Endocr Metab Disord (2025) — summary generated from the PubMed abstract.
- 2025
Rev Endocr Metab Disord3 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406